Literature DB >> 7868263

Neutrophil alkaline phosphatase activity increase in bacterial infections is not associated with a general increase in secretory vesicle membrane components.

A Karlsson1, L Khalfan, C Dahlgren, T Stigbrand, P Follin.   

Abstract

The content of alkaline phosphatase (ALP) was determined in neutrophils isolated from patients with acute bacterial infections by a standard enzyme assay. Compared with control cells, patient cells exhibited about a fivefold increase in ALP activity. There was no difference between the ALP Km values of control and patient cells, which indicates that the elevated activity in patient cells was due to the presence of increased amounts of the enzyme. The ALP isozyme in both cell types was determined to be the tissue-unspecific ALP. The fact that much of the ALP activity was measurable only in the presence of detergent suggested that the enzyme was localized in the secretory vesicles, a putative reservoir of plasma membrane components. The amount and subcellular distribution of two other secretory vesicle membrane proteins, i.e., cytochrome b and complement receptor 3, were not altered; hence, we conclude that there was no general increase in amounts of secretory vesicle membrane constituents in the patient cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7868263      PMCID: PMC173089          DOI: 10.1128/iai.63.3.911-916.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Characterization and quantification of the peroxidase in human monocytes.

Authors:  A Bos; R Wever; D Roos
Journal:  Biochim Biophys Acta       Date:  1978-07-07

2.  Specific assays for human alkaline phosphatase isozymes.

Authors:  K Hirano; H Matsumoto; T Tanaka; Y Hayashi; S Iino; U Domar; T Stigbrand
Journal:  Clin Chim Acta       Date:  1987-07-15       Impact factor: 3.786

3.  A modified procedure for the determination of leukocyte alkaline phosphatase.

Authors:  L R DeChatelet; M R Cooper
Journal:  Biochem Med       Date:  1970-08

4.  Studies of the biochemical and immunological properties of human neutrophil alkaline phosphatase with comparison to the established alkaline phosphatase isoenzymes.

Authors:  G P Smith; H Harris; T J Peters
Journal:  Clin Chim Acta       Date:  1984-09-29       Impact factor: 3.786

5.  Present status and future trends of human alkaline phosphatases.

Authors:  T Stigbrand
Journal:  Prog Clin Biol Res       Date:  1984

6.  Evidence that alkaline phosphatase from human neutrophils is the same gene product as the liver/kidney/bone isoenzyme.

Authors:  A L Gainer; R A Stinson
Journal:  Clin Chim Acta       Date:  1982-08-04       Impact factor: 3.786

7.  Role of alkaline phosphatase in phosphate uptake into brush border membrane vesicles from human intestinal mucosa.

Authors:  K Hirano; Y Iiizumi; Y Mori; K Toyoshi; M Sugiura; S Iino
Journal:  J Biochem       Date:  1985-05       Impact factor: 3.387

8.  Correlation of human neutrophil secretion, chemoattractant receptor mobilization, and enhanced functional capacity.

Authors:  M P Fletcher; B E Seligmann; J I Gallin
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

9.  Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation.

Authors:  N Borregaard; J M Heiple; E R Simons; R A Clark
Journal:  J Cell Biol       Date:  1983-07       Impact factor: 10.539

10.  Lysosomal and ultrastructural changes in human "toxic" neutrophils during bacterial infection.

Authors:  C E McCall; I Katayama; R S Cotran; M Finland
Journal:  J Exp Med       Date:  1969-02-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Purinergic regulation of neutrophil chemotaxis.

Authors:  W G Junger
Journal:  Cell Mol Life Sci       Date:  2008-08       Impact factor: 9.261

2.  Application of intracellular alkaline phosphatase activity measurement in detection of neutrophil adherence in vitro.

Authors:  Katarzyna Bednarska; Magdalena Klink; Zofia Sulowska
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.